• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in

Real-world usage of anti-seizure medications: Understanding medication side effects

by Ryan Klingler | Feb 3, 2025

Case study Real-world usage of anti-seizure medications Understanding medication side effects The relationship between epilepsy, anti-seizure medications (ASMs), and cardiac comorbidities is complex. Individuals with epilepsy may have a higher risk of developing...
De-risking clinical development and driving therapeutic innovation for heart failure

De-risking clinical development and driving therapeutic innovation for heart failure

by Ryan Klingler | Jan 29, 2025

Case study De-risking clinical development and driving therapeutic innovation for heart failure Heart failure (HF) impacts nearly 6.5 million Americans over the age of 20  in the US, with approximately 960,000 new cases each year. And HF readmission rates have...
Assessing the comparative safety of novel pulmonary embolism treatments

Assessing the comparative safety of novel pulmonary embolism treatments

by Ryan Klingler | Jan 29, 2025

Case study Assessing the comparative safety of novel pulmonary embolism treatments Each year, approximately 900,000 patients in the US are affected by a pulmonary embolism, a blood clot causing a blockage in one or more pulmonary arteries in the lungs. Despite the...

Share this


Recent posts

  • ASCO 2025: Development and validation of machine learning risk prediction models for detection of early-onset colorectal cancer
  • ASCO 2025: Changes in colorectal cancer screening and detection following USPSTF expanded recommendations
  • Prostate cancer is in the headlines — and early detection has never been more important

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice